If you are in the business of selling vaccines or collecting kickbacks for moving product, then the next best thing to the COVID injectables appears to be the Monkey Pox Jab. What is it, exactly? Well, it is an actual vaccine.
Smallpox/monkeypox vaccine (JYNNEOS™) is made using weakened live vaccinia virus and cannot cause smallpox, monkeypox, or any other infectious disease.
JYNNEOS™ is approved by the Food and Drug Administration (FDA) for prevention of smallpox and monkeypox disease in adults 18 years or older at high risk for smallpox or monkeypox infection.
- CDC recommends JYNNEOS™ for certain laboratory workers and emergency response team members who might be exposed to the viruses that cause orthopoxvirus infections.
- CDC recommends consideration of the vaccine for people who administer ACAM2000®, or who care for patients infected with orthopoxviruses.
JYNNEOS™ is usually administered as a series of 2 injections, 4 weeks apart. People who have received smallpox vaccine in the past might only need 1 dose.
Booster doses are recommended every 2 or 10 years if a person remains at continued risk for exposure to smallpox, monkeypox, or other orthopoxviruses. Your health care provider can give you more information.
Great, but new research suggests it only provides (whatever protection it offers) for a few months.
Natural infection leads to higher antibodies
Mpox serum neutralizing antibody (NAb) titers were detectable in only a few participants following one or two doses of Jynneos at 3 months, the authors said. In contrast, high titers (median, 965) of mpox NAbs were detected at 3 months following natural infection and persisted at 9 months post-infection (median, 284).
Barouch said the antibody levels confirm previous findings that showed Jynneos provides 66% efficacy as a two-dose regimen and 36% efficacy as a one-dose regimen at peak immunity (3 weeks) during the 2022 mpox outbreak.
Vaccine-generated mpox antibodies largely waned after 6 to 12 months, he said, and at 12 months, antibody levels in participants who had two doses of vaccine were comparable or lower than peak antibody responses in people who received one dose of vaccine.
The Human body is better than big pharma again. Surprise! But that doesn’t keep narrative-monkey politicians and Big Pharma investors happy. They like “cures” that must be regularly reintroduced to “at-risk” populations to prevent infection.
Keeping everyone terrified of an infection keeps the drugs rolling and the profits pouring in.
Modern medicine has been reduced to using governments as proxies for profits regardless of safety or efficacy. The fact that a majority of the people subjected to this practice are of color ought to ruffle a few progressive feathers, but the best we can expect is some nonsense about colonialism, white privilege (or supremacy), and perhaps some rants about climate change.
Whatever keeps the gravy pouring.
